GLP-1 weight-loss drugs show unexpected psychiatric benefits in largest ...
2 days agoDiscussed by: Psychiatric Times, Brown University addiction researchers, and multiple experts in Science Media Centre commentary If purpose-built randomized controlled trials in psychiatric populations replicate the observational findings, semaglutide or similarGLP-1drugs could receive FDA approval for psychiatric indications—depression,anxiety, or substance use disorders. This would ...
source: https://newzino.com